Brain Stimulation and Exercise Games Tested in Motor Neuron Disease
Tests brain stimulation with exercise games in adults with ALS.
Key facts
- Who runs it
- Chulalongkorn University
- Where
- Bangkok, ThailandSee the site
- Trial code
- Registry title
- Non-invasive Brain Stimulation and Exercise Intervention for Patients With Motor Neuron Disease
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 1 Aug 2025
- Expected to end
- 30 Dec 2027
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Personalized rTMS
- Standard rTMS
- Sham rTMS
- Record updated
- 25 September 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 18 to 80 with any type of motor neuron disease of mild to moderate severity. It tests magnetic brain stimulation together with exercise games.
- Age
- 18 to 80 years
- Sex
- All sexes can join.
- Disease stage
- Any type of motor neuron disease (MND), mild to moderate, severity level between 1 and 3 on the Sinaki-Mulder scale.
Main reasons for not taking part
- History of other neurological disorders, such as stroke
- Use of ventilatory support
- Severe dementia
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Participants aged between 18 and 80 years
- Diagnosed with any type of motor neuron disease (MND)
- Have mild to moderate severity, as assessed by the Sinaki-Mulder scale, with a severity level between 1 and 3
Who cannot take part
- History of other neurological disorders, such as stroke
- Severe dementia
- Use of ventilatory support
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Where in Thailand
- King Chulalongkorn Memorial hospital, The Thai Red Cross SocietyBangkok, ThailandContact: Jakkrit Amornvit, MDTaking people
About the trial
What the trial wants to find out
Motor neuron disease (MND) is a progressive neurological disorder involving degeneration of motor neurons, leading to muscle weakness, speech and swallowing difficulties, and respiratory failure. This study aims to develop a novel treatment approach combining personalized repetitive transcranial magnetic stimulation (rTMS) with mixed reality (MR) exercise-based games (exergames) to slow disease progression and improve quality of life. In this randomised controlled trial study will compare three groups: (1) rTMS with MR exercise (personalized intervention), (2) rTMS with MR exercise (standard intervention), and (3) sham rTMS with MR exercise. Outcomes will be assessed at baseline, 3 months, and 6 months post intervention. The long-term goal is to implement this approach in clinical settings to enhance care for people with MND.
The 3 groups in the trial
- Personalized intervention groupTreatment being tested
Participants will receive personalised repetitive transcranial magnetic stimulation mixed reality.
Treatment: Personalized rTMS
- Standard intervention groupExisting treatment, for comparison
Participants will receive standard repetitive transcranial magnetic stimulation plus mixed reality.
Treatment: Standard rTMS
- Sham groupSham treatment, for comparison
Participants will receive sham repetitive transcranial magnetic stimulation mixed reality.
Treatment: Sham rTMS
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Non-invasive Brain Stimulation and Exercise Intervention for Patients With Motor Neuron Disease
- Plain-language title
- Brain Stimulation and Exercise Games Tested in Motor Neuron DiseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT07067229, who can take part
- Record updated
- 25 September 2025